21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The Structural Basis for Ras Activation of PI3Kα Lipid Kinase

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          PI3Kα is a principal Ras effector that phosphorylates PIP 2 to PIP 3 in the PI3K/Akt/mTOR pathway. How Ras activates PI3K has been unclear: is Ras’ role confined to PI3K recruitment to the membrane or does Ras activation also involve allostery? Recently, we determined the mechanism of PI3Kα activation at the atomic level. We showed the vital role and significance of conformational change in PI3Kα activation. Here, by a ‘best-match for hydrogen-bonding pair’ (BMHP) computational protocol and molecular dynamics (MD) simulations, we model the atomic structure of KRas4B in complex with the Ras binding domain (RBD) of PI3Kα, striving to understand the mechanism of PI3Kα activation by Ras. Point mutations T208D, K210E, and K227E disrupt the KRas4B–RBD interface in the models, in line with the experiments. We identify allosteric signaling pathways connecting Ras to RBD in the p110α subunit. However, the observed weak allosteric signals coupled with the detailed mechanism of PI3Kα activation make us conclude that the dominant mechanistic role of Ras is likely to be recruitment and restriction of the PI3Kα population at the membrane. Thus, RTK recruits the PI3Kα to the membrane and activates it by relieving its autoinhibition exerted by the nSH2 domain, leading to exposure of the kinase domain, which permits PIP 2 binding. Ras recruitment can shift the PI3Kα ensemble toward a population where the kinase domain surface and the active site position and orientation favor PIP 2 insertion. This work helps elucidate Ras-mediated PI3K activation and explores the structural basis for Ras–PI3Kα drug discovery.

          Related collections

          Author and article information

          Journal
          100888160
          32386
          Phys Chem Chem Phys
          Phys Chem Chem Phys
          Physical chemistry chemical physics : PCCP
          1463-9076
          1463-9084
          2 June 2019
          05 June 2019
          05 June 2020
          : 21
          : 22
          : 12021-12028
          Affiliations
          [a ]Computational Structural Biology Section, Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, U.S.A.
          [b ]Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
          Author notes

          Author Contributions

          MZ, HJ, and RN conceived and designed the study. MZ conducted most of the simulations and analyzed the results. MZ, HJ, and RN wrote the paper.

          [1 ]To whom correspondence should be addressed. R.N. nussinor@ 123456mail.nih.gov
          Article
          PMC6556208 PMC6556208 6556208 nihpa1032838
          10.1039/c9cp00101h
          6556208
          31135801
          fe77127b-ceee-497d-9b94-19ab0360af32
          History
          Categories
          Article

          allostery,K-Ras4B,Lipid kinase,Ras effector,KRas4B,PI3K activation,allosteric

          Comments

          Comment on this article